<DOC>
	<DOCNO>NCT02495909</DOCNO>
	<brief_summary>Objective Hypotheses : This project overall objective implement evaluate new approach reduce current future burden urinary schistosomiasis young child use antihelminthic drug Praziquantel . The project aim ( 1 ) determine operational health benefit treat schistosome infection early re-infection morbidity reduction , ( 2 ) determine gut urine microbiome structure ( specie diversity abundance ) risk factor S. haematobium infection morbidity , ( 3 ) elucidate factor underlie mechanism mediate reduction/reversal schistosome-related morbidity resistance infection/re-infection young child .</brief_summary>
	<brief_title>Childhood Schistosomiasis : Novel Strategy Extending Benefits/Reach Antihelminthic Treatment</brief_title>
	<detailed_description>This study aim refine current paediatric treatment schistosomiasis use drug Praziquantel ( PZQ ) improve current future health pre-school child infant . Praziquantel cheap , highly efficacious safe , present realistic opportunity use pre-existing tool modify way benefit child health development . The study focus child age 3 5 year age , compare impact early vs. later treatment PZQ current future health status child . By kill worm PZQ stop morbidity relate presence worm egg anaemia , abdominal pain , diarrhoea blood urine well induce immune response associate reduced re-infection rate . Therefore study investigate immediate health benefit treat pre-school child infant effect treatment re-infection rate .</detailed_description>
	<mesh_term>Schistosomiasis</mesh_term>
	<mesh_term>Anthelmintics</mesh_term>
	<criteria>1. lifelong resident area 2. provide least 2 urine 2 stool parasitological examination 3. give blood sample treatment episode 4. negative schistosome , hookworm , Trichuris Ascaris 5. frequent contact infective water 1. clinical sign tuberculosis malaria 2. present fever 3. recent major operation , illness vaccination 4. previously receive antihelminthic treatment 5. infected helminth</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>paediatric schistosomiasis</keyword>
	<keyword>morbidity</keyword>
	<keyword>immunology</keyword>
</DOC>